Diazepam (relanium) vs. Midazolam for premedication: A review of the evidence and clinical implications
Humanities & Social Sciences Reviews · 22.08.2026 · 14 (2) · 93-97
DOI: 10.18510/hssr.2026.14211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Humanities & Social Sciences Reviews, online erschienen am 22.08.2026. Verfasst von Konrad Tomasik und 9 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Research objective: The purpose of this review is to compare diazepam and midazolam in terms of clinical efficacy, safety, and practical implications for modern anesthesiology, with particular emphasis on same-day surgery and the elderly patient population. Methodology: The article presents a narrative review of randomized trials, comparative studies, systematic reviews, meta-analyses, and current guidelines concerning perioperative benzodiazepine use, with attention to anxiolysis, sedation, amnesia, recovery, respiratory depression, delirium, and risks in older adults. Main conclusions: Midazolam is currently preferred more often because of its faster onset and shorter, more predictable clinical effect. Diazepam remains effective, but its longer duration of action and active metabolites increase the risk of accumulation and residual sedation. Application of the study: The comparison supports individualized premedication decisions based on the patient's age, procedure type, planned discharge, comorbidities, concomitant medications, and risk of postoperative delirium. Originality/Novelty of the study: The review integrates evidence on efficacy, safety, pharmacokinetics, and contemporary perioperative care models to clarify the current clinical roles of diazepam and midazolam.
Zitieren
APA
Tomasik, K., Tomasik, A., Mantur, L., Koszuta, K. A., Przybyłko, T., Koszuta, J. M., Agaciak, K., Wasąg, P. Z., Koszuta, P., & Marcinkiewicz, N. (2026). Diazepam (relanium) vs. Midazolam for premedication: A review of the evidence and clinical implications. Humanities & Social Sciences Reviews, 14(2), 93-97. https://doi.org/10.18510/hssr.2026.14211
Vancouver
Tomasik K, Tomasik A, Mantur L, Koszuta KA, Przybyłko T, Koszuta JM, et al. Diazepam (relanium) vs. Midazolam for premedication: A review of the evidence and clinical implications. Humanities & Social Sciences Reviews. 2026;14(2):93-97. doi:10.18510/hssr.2026.14211
BibTeX
@article{Tomasik2026,
author = {Tomasik, Konrad and Tomasik, Anastazja and Mantur, Laura and Koszuta, Karina Aleksandra and Przybyłko, Tomasz and Koszuta, Julia Magdalena and Agaciak, Kaja and Wasąg, Pola Zofia and Koszuta, Przemysław and Marcinkiewicz, Natalia},
title = {Diazepam (relanium) vs. Midazolam for premedication: A review of the evidence and clinical implications},
journal = {Humanities & Social Sciences Reviews},
year = {2026},
volume = {14},
number = {2},
pages = {93--97},
doi = {10.18510/hssr.2026.14211}
}
EUVIMED